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More patients with adenocarcinoma of the stomach are presenting
at an earlier stage (Sue-Ling et al, 1993), yet most who undergo
surgery with curative intent will ultimately die of recurrent disease
(Papachristou and Fortner, 1981). Relook laparotomy and post-
mortem studies have demonstrated that the majority of patients
who have recurrent disease will have peritoneal metastases
(Gunderson and Sosin, 1982). Peritoneal recurrence presumably
stems from transcoelomic dissemination of malignant cells in the
pre- or perioperative period (Sugarbaker et al, 1988). Despite this,
the role of peritoneal cytological evaluation in predicting failure of
gastric cancer resections has attracted little interest in the West.
Japanese workers, by contrast, place great store in the determina-
tion of peritoneal cytology status in patients undergoing surgery
for gastric cancer (Kaibara et al, 1987; Boku et al, 1990), and have
even used peritoneal cytology to examine the effect of adjuvant
chemotherapy (Iitsuka et al, 1979).
Open lavage, performed immediately before tumour resection,
is a crude but simple technique for sampling potentially free cells
within the peritoneal cavity. A previous pilot study at this institu-
tion demonstrated that less than one-third of patients with
advanced gastric cancer had positive peritoneal cytology at the
time of operation (Murphy et al, 1993). This is significantly fewer
cases than the proportion which might be expected to die with
peritoneal metastatic recurrent disease; historically, up to 80%
(Gunderson and Sosin, 1982). This underdetection may be due to
the insensitivity of the sampling technique, or it may be that the
process of surgical resection itself encourages the dissemination of
malignant cells (Cunliffe and Sugarbaker, 1989). If detection of
free malignant cells in the peritoneal cavity is to be used to identify
patients at risk of peritoneal recurrence and prove useful in the
selection of patients for adjuvant therapy, its technique needs
critical evaluation.
The aims of this study were to evaluate the technique of peri-
toneal lavage with alternative peritoneal cytological sampling
strategies, to discover whether surgical resection can be shown to
initiate peritoneal dissemination of tumour cells and, hence,
explain the unexpectedly low yield of preresection peritoneal
lavage, and lastly to determine the prognostic significance of peri-
toneal cytological evaluation.
Ethical approval for this study was granted by the Joint Ethics
Committee of Newcastle District Health Authority and the
University of Newcastle upon Tyne.
PATIENTS AND METHODS
Patients
Patients undergoing elective surgery for adenocarcinoma of the
stomach were eligible for this study. Recruitment began in April
Peritoneal cytology in the surgical evaluation of gastric
carcinoma
N Hayes1, J Wayman1, V Wadehra2, DJ Scott2, SA Raimes1 and SM Griffin1
1The Northern Oesophago-Gastric Cancer Unit and 2Institute of Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
Summary Many patients undergoing surgery for gastric carcinoma will develop peritoneal metastases. A method to identify those patients at
risk of peritoneal recurrence would help in the selection of patients for adjuvant therapy. Peritoneal cytology has received little attention in the
West, but may prove a useful additional means of evaluating patients with gastric cancer. The aims of this study were to evaluate sampling
techniques for peritoneal cytology in patients with gastric cancer, to assess the prognostic significance of free peritoneal malignant cells and
to discover the effect of the operative procedure on dissemination of malignant cells. The study is based on 85 consecutive patients
undergoing surgical treatment of gastric cancer and followed up for 2 years or until death. Peritoneal cytology samples were collected at
laparoscopy, and at operation prior to resection by intraperitoneal lavage and serosal brushings. After resection, samples were taken by
peritoneal lavage, imprint cytology of the resected specimen and post-operatively by peritoneal irrigation via a percutaneous catheter.
Malignant cells were diagnosed by two independent microscopists. Preoperative peritoneal lavage yielded malignant cells in 16 out of 85
cases (19%). The yield of free malignant cells was increased by using serosal brushings (by four cases) and imprint cytology (by two cases);
all of the cases had evidence of serosal penetration. One serosa-negative case exhibited positive cytology in the post-resection peritoneal
specimen in which the preresection cytology specimen was negative. Survival was worse in the cytology-positive group (c2 = 25.1; P <
0.0001). Among serosa-positive patients, survival was significantly reduced if cytology was positive, if cases yielded by brushings and imprint
cytology were included (log-rank test = 8.44; 1 df, P = 0.004). In conclusion, free peritoneal malignant cells can be identified in patients with
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1992 and took place in four surgical units within the former
Northern Region (see Acknowledgements). All participating
patients were interviewed by the principal author before providing
written, informed consent.
Intraoperative staging
At operation, gastric cancers were staged for local, nodal and
metastatic spread. Any apparent breach of the gastric serosal layer
was mapped using a clear plastic grid (Opsite Flexigrid, Smith and
Nephew, Hull, UK), and the surface area was calculated. The
extent of surgical resection was not controlled by the study, but left
to the discretion of the surgeon involved in each case.
Specimen collection
Preresection
Peritoneal washing Immediately on opening the abdomen,
100 ml of warm saline was instilled onto the serosa overlying the
tumour. The fluid was then aspirated from the abdominal recesses,
including the pouch of Douglas. If ascites was present, this fluid
was aspirated instead of performing a wash. A minimum of 80%
(80 ml) retrieval was required for these and all other washings
to be regarded as adequate for analysis. In practice, this was
achievable in all cases.
Laparoscopic washing Patients undergoing laparoscopic
staging before open surgery were included in this study. Saline
lavage was performed at the time of laparoscopy using a combined
suction/irrigation rigid catheter passed through a 5 mm epigastric
port. Saline (100 ml) was instilled over the anterior surface of the
stomach and aspirated under direct vision.
Peritoneal brushings These were obtained by lightly sweeping
the serosa overlying the tumour with a sterilized brush
(CerviBrush+, CellPath, Hemel Hempstead, UK). Brushings were
made over the entire area of suspected serosal penetration using a
single brush sweeping the area four times. The slide was then
smeared onto a series of slides for immediate fixation.
Post-resection
Imprint cytology When palliative or curative resection was
possible, the specimen was handed to an assistant and slides
coated with poly-L-lysine (Sigma, Poole, UK) were pressed
against the serosa overlying the tumour and immediately fixed.
Peritoneal washing A second washing was obtained after
completion of the surgical manoeuvres, but before any therapeutic
lavage (e.g. with tetracycline solution) was used. The saline lavage
was particularly directed at the gastric bed and pedicles where
resection had taken place. This procedure was not included if the
patient had only an exploratory laparotomy.
Peritoneal irrigation At the end of the operation, a 5-mm
Jackson—Pratt wound drain (Baxter Healthcare, Deerfield, IL, USA)
was left in the pouch of Douglas or rectovesical space and dedicated
for peritoneal irrigation, usually performed on the first and fifth
post-operative days. After clamping the other wound drains, 200 ml
of warmed saline was infused via the pelvic drain, left in situ for
5 min and then allowed to drain back into the infusion bag.
Specimen processing
All fluid samples were spun at 1500 r.p.m., the precipitate resus-
pended and then spun onto poly-L-lysine coated slides by centrifuge
(Cytospin 2, Shandon Southern Productions, Runcorn, UK).
Slides from each sample were fixed and stained by
Papanicolaou and Giemsa methods using routine automated cycles
as well as manual periodic acid—Schiff staining with or without
diastase incubation.
Cytological interpretation
All slides were initially read by the principal author and were later
second-read by a consultant cytopathologist (VW), who was
unaware of the surgical or histological findings. Interobserver
variation related to the assessment of staining was less than 5%.
Discordant cases were re-evaluated by the two observers using
double-headed light microscopy. In addition to the four stains
described, specimens were examined using monoclonal antibodies
to CK, CEA, p53, AUA 1 and B72 (data not presented). There
were no instances in which standard techniques failed to identify
malignant cells found in these latter techniques, thus we can be
confident that the incidence of false-negative results because of
post-collection sampling will be very low. Slide preparations were
deemed inadequate if there was insufficient cellular material for
diagnosis, if blood staining was so heavy that it prevented cellular
examination, or if there had been a fault of fixation or staining.
Malignant cells were recognized under light microscopy using
standard criteria (Koss, 1992), namely by presence of large,
hyperchromatic nuclei, abnormal nuclear chromatin, prominent
nucleolus, distorted nuclear outline, increased nuclear/cytoplasmic
ratio, intracytoplasmic acid or neutral mucin vacuoles, or hetero-
geneity of cells with clumping of groups. Each slide was classified
as inadequate, benign, malignant or suspicious. The latter category
was reserved for specimens in which scant solitary positive cells
had been imperfectly fixed.
Histological interpretation
The gastrectomy specimens were processed routinely and inter-
preted by a single experienced pathologist (DJS) blinded to
operative and cytological findings according to a standardized
dissection protocol. Specimens were staged according to the
unified guidelines developed by the Union Internacionale Contra
la Cancrum, the Japanese Research Society for Stomach Cancer
and the American Joint Committee on Cancer (Kennedy, 1987).
Follow-up
All patients were followed up for 2 years or until death. To ensure
accurate survival data, the hospital notes were clearly labelled and
the general practitioners informed of the nature of the study such that
date of death was communicated promptly to the authors. Survival
was confirmed by contact with general practitioners at 2 years.
Statistical analysis
Continuous data was compared using the Mann—Whitney U-test,
ordinal data by chi-squared test, and survival, calculated by the
method of Kaplan—Meier, by the log-rank test. Significance was
assumed if P < 0.05.522 N Hayes et al
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RESULTS
Patients
Eighty-nine patients were recruited in the 20-month period from
April 1992. Four patients were excluded from analysis after unex-
pected post-resection pathological reports: two were discovered to
have cancer arising in Barrett￿s oesophagus, two were discovered
to have benign gastric ulceration despite pre-operative reports of
high-grade dysplasia in a non-healing gastric ulcer. The median
age of patients was 69 (range 32—95), 66 were men.
Operative findings and procedures
Sixty-three of the 85 patients (74%) had macroscopic evidence of
serosal penetration by tumour. Sixty-three had evidence of lymph
node involvement. Twenty cases had evidence of peritoneal
dissemination at the time of operation, five of whom had liver
metastases also. A further three cases had liver metastasis without
obvious peritoneal deposits.
Thirteen cases were unsuitable for resection and simple bypass
was performed in five of these, 11 cases with advanced disease had
palliative resections whereas the remainder underwent potentially
curative D1 (47) or D2 (14) gastrectomy.
Peritoneal cytology (Table 1)
Certain specimens were regarded as unreliable because either no
cells at all or heavily bloodstained specimens were obtained.
Inadequate specimens occurred in 9 out of 85 of preoperative peri-
toneal washes, 8 out of 83 post-resection washes, 11 out of 78 serosal
brushings, 8 out of 36 imprint specimens, 0 out of 81 early post-
operative irrigations and 1 out of 74 late post-operative irrigations.
In total, 23 patients (27%) had positive peritoneal malignant
cytology. Of these cases, 22 out of 23 were observed to have
serosal penetration by the primary tumour. Positive cytology was
associated with a greater surface area of penetration [11.5 (7—14)
vs. 5.5 (1—9) cm2; P < 0.05]. There was no difference in sex ratio
or age between the cytology-positive and-negative groups.
Peritoneal lavage alone yielded unequivocal malignant cytology
in 16 out of 85 (19%) cases. Two patients with positive cytology at
laparoscopy had inoperable disease and no further operative proce-
dure was performed. Eight patients had ascites at the time of
laparotomy or laparoscopy and all were shown to have free malig-
nant cells. Serosal peritoneal brushings were positive in 6 of the 78
cases examined, four of these cases had been negative according to
simple lavage. Imprint cytology yielded malignant cells in 6 of 36
cases, two had not been detected by simple lavage.
Eight patients with positive cytology underwent no operation or
simple bypass procedure, six had palliative resection and nine had
potentially curative (R0) resection. Of the nine patients with posi-
tive cytology who had undergone potentially curative resection,
two were detected by preresection peritoneal lavage alone, two by
imprint cytology alone, two by pre- and post-resection lavage and
one by imprint cytology preresection and post-resection lavage.
Malignant cells persisted post-resection in 9 of the 14 positive
cases. In one case, preresection cytology was negative and post-
resection cytology was positive.
Table 1 Number of positive cytological cases (including cumulative incidence of new positive findings in addition to those detected by preresection washings)
for each method of sampling
No. cases Malignant cytology New cases of Cumulative incidence of
evaluated detected malignant cytology malignant cytology
(+ ‘suspicious’ detected
cases)
Preresection
Lavage (including laparosocopy) 85 16 (2) 16 16
Serosal brushing 78 6 (9) 4 20
Subtotal 85 20
Post-resection
Imprint 36 6 (3) 2 22
Lavage 83 6 (4) 1 23
Subtotal 85 23
Post-operative
Irrigation 1 81 2 (2) 0 23
Irrigation 2 74 3 (3) 0 23
Total 85 23
Table 2 Cytology status of patients with respect to T, N and M stage
Cytology Total
Stage Negative Positive
T* T1 11 0 11
T2 25 1a 26
T3 20 16 36
T4 6 6 12
N** N0 19 4 23
N1 30 12 42
N2 13 7 20
M*** M0 53 12 65
M1 9 11 20
Total 62 23 85
*c2 = 19.89; 3 d.f., P < 0.001; **c2 = 1.77; 2 d.f., P = n/s (discrepancy with
incidence of lymph node metastases described in operative findings suggest,
overall, one case was over-staged by surgeon); *** c2 = 10.35; 1 d.f.,
P = <0.01 (discrepancy with incidence of metastases described in operative
findings suggest, overall, three cases were over-staged by surgeon). aOne
patient had no serosal breach; cytology was negative before, but positive
after, gastric resection.Peritoneal cytology in gastric carcinoma 523
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Histological interpretation (Table 2)
Positive cytological status was associated with significantly higher
tumour (T) and metastasis (M) staging than the negative group, but
no association was demonstrated between nodal (N) status and
cytology.
Survival
At 2-year follow-up, 22% of patients with positive cytology had
survived, compared with 66% of the cytology-negative group (log-
rank test = 25.10, 1 d.f., P < 0.0001). Favourable prognosis was
also associated with a low TNM stage (log-rank test = 29.26, 3 d.f.,
P < 0.0001). Among patients who underwent a potentially curative
(R0) resection, positive peritoneal cytology predicted poor survival
(log-rank test = 10.8, 1 d.f.; P = 0.001). Peritoneal cytology from
peritoneal lavage alone was not of prognostic significance in cases
of T3 and T4, pathologically confirmed, serosa-positive disease
(log-rank test = 0.33 1 d.f.; P = ns). Identification of cases by
serosal brushings and imprint cytology in addition to cases detected
by peritoneal lavage was associated with poor prognosis (log-rank
test = 8.44; 1 d.f., P = 0.004) (Figure 1).
DISCUSSION
Despite progress in recent years towards the early detection of
gastric cancer (Sue-Ling et al, 1993), most patients will already
have advanced disease at diagnosis (Allum et al, 1989a). The
majority of patients will die of recurrent disease, even if surgery is
thought to be curative at the time. A minority of patients with
advanced gastric cancer have hitherto been shown to have free
malignant cells at laparotomy (Nakajima et al, 1978; Boku et al,
1990; Bonenkamp et al, 1996). In the West, the success of peri-
toneal cytology has been limited. The Dutch Gastric Cancer Trial
demonstrated positive cytology in only 7.1% of all patients with
gastric cancer and 12% of cases with serosal invasion
(Bonenkamp et al, 1996). The expected incidence of peritoneal
metastasis suggests transcoelomic dissemination occurs more
frequently than is demonstrated by cytology of preresection lavage
fluid (Gunderson and Sosin, 1982).
In our study, post-resection peritoneal sampling was associated
with a low yield of malignant cells. This may be explained to some
extent by the changes associated with the surgical manoeuvre. In
addition to blood staining, we found a considerable increase in the
numbers of polymorphonuclear cells and mesothelial cells which
change in appearance from regular, monotonous cells to bizarre,
heterogeneous, multinucleated cells after surgery (Soosay et al,
1991). Any malignant cells remaining in the abdominal cavity
after resection may be swamped by this population explosion of
nucleated cells, making their detection more difficult. In addition,
malignant cells rapidly adhere to either normal or denuded peri-
toneum. Surgical insult may contribute to this process by trig-
gering the fibrin cascade which enmeshes malignant cells and
facilitates their implantation (Sugarbaker et al, 1988). This too
may explain the low yield of cells after resection.
Only one example occurred in which malignant cells could be
identified post-operatively in a patient with a negative preresection
status. However, in over half the cases with positive cytology on
preresection examination, the subsequent samples were negative.
The solitary patient in whom cytology status changed from negative
to positive probably represents genuine cell dissemination that our
techniques have failed to detect in an unknown proportion of other
post-operative patients. This case, a T2 tumour, suggests that manip-
ulation of the tumour can lead to peritoneal dissemination. Given
that simple diagnostic lavage is an insensitive method for detecting
free peritoneal cells, this single case is likely to understate the clin-
ical problem of operative tumour dissemination. After therapeutic
tetracycline or saline lavage, in only 3 of the 23 cases with positive
cytology could free malignant peritoneal malignant cells be identi-
fied. This evidence supports the long-held surgical philosophy that
careful tumour handling and adequate lavage at the end of cancer
surgery may help to reduce the extent of malignant cell inoculation.
In our series, serosal brushings revealed relatively few positive
cases despite histologically proven serosal penetration with tumour.
The yield is less than one would expect if performing a brushing of
the mucosal surface of the tumour. This might be explained by the
reaction of adjacent mesothelial cells to the presence of tumour.
Rapid healing of peritoneal wounds is well recognized, and it is
likely that this phenomenon occurs to some extent when the
visceral peritoneum is breached by tumour rather than by the
scalpel. Bizarre mesothelial cell morphology was mainly encoun-
tered prior to resection in cases with tumour extending close to, or
through, the serosal barrier.
In our series, 22 of 48 (46%) patients with locally advanced
(pT3, pT4) cancer had positive peritoneal cytology. Although peri-
toneal lavage was the most sensitive single technique for demon-
strating free peritoneal malignant cells, detecting malignant cells
in 16 of 48 (33%) cases with locally advanced disease, the yield of
free cells is significantly increased by the addition of both brush
cytology and imprint cytology. By these methods, the incidence of
positive peritoneal cytology begins to approach and hence predict
the expected incidence of recurrence and death which may be as
high as 80% (Gunderson and Sosin, 1982).
It has long been appreciated that patients with advanced gastric
cancer offered surgery alone have little hope of being cured, and
interest has recently been focused on the role of adjuvant therapy.
Systemic chemotherapeutic agents have been investigated singly or
in combination in randomized trials, but no therapy has yet been
shown to be effective and the regimens are often associated with
a high incidence of systemic side-effects (Allum et al, 1989b;
Hallissey et al, 1994). Intraperitoneal chemotherapy administered
as aqueous solution (Nakajima et al, 1978) or adsorbed onto carbon
particles (Hagiwara et al, 1992) in the early post-operative period
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appears to be well tolerated (Cunliffe and Sugarbaker, 1989). By
this strategy, chemotherapeutic agents are delivered in maximum
concentration to the site of maximum cancer cell contamination, at
the time when the peritoneum is most vulnerable to implantation.
The peritoneal cytology status of a patient is an indicator of
prognosis which can be determined rapidly using standard labora-
tory equipment and techniques. Although the role of adjuvant
therapy for advanced gastric cancer requires further evaluation,
peritoneal cytology may help to select those patients who have the
most to gain from such treatment in the immediate perioperative
period, before full detailed histological information is available.
In conclusion, addition of serosal brush cytology and imprint
cytology to ￿conventional￿ peritoneal lavage significantly
increases the yield of free malignant peritoneal cells. Examination
of free peritoneal malignant cells in this way predicts poor prog-
nosis in cases of gastric cancer and among patients with advanced
disease. Future studies evaluating the role of adjuvant treatments
should take account of peritoneal cytological status, as well as
conventional TNM staging criteria; this evaluation may have a
prominent role in the selection of patients who have the most to
gain from adjuvant therapy.
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